Interactive Tool: BPH Symptom Score Questionnaire
This tool is for individuals with a prostate who are experiencing lower urinary tract symptoms. It asks about your about your urinary symptoms from BPH and gives you a score based on how severe your symptoms are. Your score on this questionnaire may help you think about if and how you want to treat the problem. The score is called the International Prostate Symptom Score (IPSS) and is based on the American Urological Association (AUA) Symptom Index.1 It is commonly used to screen for, evaluate, track the symptoms of, and suggest management of the symptoms of benign prostatic hyperplasia (BPH).
1McVary KT, et al. (2010). Guideline on the management of benign prostatic hyperplasia (PH). In American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH)., pp. 2-34. Linthicum, MD: American Urological Association Education and Research.
Over the last month, how often have you:
Human Health News
Nanotechnology targets cancer through breast ducts
Breast cancer remains a significant health challenge worldwide. While advancements in treatment have improved survival rates, the search for more targeted and effective therapies continues. Nanotechnology-based intraductal drug delivery aims to revolutionize local treatment and prevention of breast cancer by delivering nanocarriers with therapeutic agents directly to the site of the disease.
Vision loss and dementia risk
A recent study found that up to 19% of dementia cases may be attributable to impaired vision. The study, published in JAMA Ophthalmology, showed that vision loss may have even more of an impact on the risk of dementia than previously thought. Hearing loss is also considered a modifiable risk factor for dementia, supporting the notion that sensory engagement is critical for brain health.
Blood tests predict cardiovascular disease
Cardiovascular disease is the leading cause of death worldwide. Heart attacks, strokes, and other heart-related conditions claim millions of lives each year — more than cancer. In the U.S., cardiovascular disease kills someone every 33 seconds, and is responsible for more than 20% of all deaths, according to the Centers for Disease Control. But what if a simple blood test could help predict heart disease decades in advance?
Nanotechnology targets cancer through breast ducts
Breast cancer remains a significant health challenge worldwide. While advancements in treatment have improved survival rates, the search for more targeted and effective therapies continues. Nanotechnology-based intraductal drug delivery aims to revolutionize local treatment and prevention of breast cancer by delivering nanocarriers with therapeutic agents directly to the site of the disease.
Vision loss and dementia risk
A recent study found that up to 19% of dementia cases may be attributable to impaired vision. The study, published in JAMA Ophthalmology, showed that vision loss may have even more of an impact on the risk of dementia than previously thought. Hearing loss is also considered a modifiable risk factor for dementia, supporting the notion that sensory engagement is critical for brain health.
Blood tests predict cardiovascular disease
Cardiovascular disease is the leading cause of death worldwide. Heart attacks, strokes, and other heart-related conditions claim millions of lives each year — more than cancer. In the U.S., cardiovascular disease kills someone every 33 seconds, and is responsible for more than 20% of all deaths, according to the Centers for Disease Control. But what if a simple blood test could help predict heart disease decades in advance?
Regional variation in Alzheimer’s and dementia diagnoses
Different parts of the United States have different rates of Alzheimer’s diagnoses. Scientists from the University of Michigan determined that regional variation was due to risk factors related to the specific population as well as the intensity of new cases diagnosed.
